Futurism on MSN12h
Hims Is Begging Customers to Lobby the FDA to Keep Its Ozempic Knockoffs Legal
Hims — the next gen telehealth startup that made waves by taking the eye contact out of erectile dysfunction treatment. Of ...
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.
The Georgia Straight21d
Top 8 Best Weight Loss Supplements for Men in 2025
we have identified the best weight-loss supplement for men on the market. Best Weight Loss Supplements for Men We know how challenging it can be to lose weight, especially for men. That’s why we ...
Hims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1s
Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering ...
Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast.
The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching End
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
Yahoo Finance24d
Hims & Hers' Weight-Loss Bet Hits a Wall--Is the Stock's $6 Billion Surge About to Unravel?
Now, the real test begins for Hims. The company poured millions into marketing$16 million alone on a Super Bowl adand built its growth story around weight loss. But with GLP-1 sales vanishing ...